Genetic Technologies
GENE
#11103
Rank
A$5.3 M
Marketcap
A$1.09
Share price
0.00%
Change (1 day)
-70.95%
Change (1 year)

Genetic Technologies (GENE) - Total debt

Total debt on the balance sheet as of June 2024 : A$0.83 Million

According to Genetic Technologies's latest financial reports the company's total debt is A$0.83 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Genetic Technologies - Total debt on balance sheet (from 2004 to 2024)

Total debt by year

Year Total debt Change
2024-06-30A$0.87 M64.25%
2023-06-30A$0.53 M-18.34%
2022-06-30A$0.65 M219.81%
2021-06-30A$0.2 M-57.65%
2020-06-30A$0.48 M
2019-06-30N/A
2015-06-30A$0.02 M-99%
2014-06-30A$2.5 M
2013-06-30N/A-100%
2012-06-30A$0.01 M-73.85%
2011-06-30A$0.06 M-82.26%
2010-06-30A$0.38 M2.46%
2009-06-30A$0.37 M25.23%
2008-06-30A$0.29 M-43.08%
2007-06-30A$0.52 M-68.87%
2006-06-30A$1.68 M-17.58%
2005-06-30A$2.04 M193.31%
2004-06-30A$0.69 M-0.11%
2003-06-30A$0.69 M
2002-06-30N/A-100%
2001-06-30A$0.12 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
A$60.89 B 7,263,746.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$9.13 B 1,089,588.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$38.00 B 4,533,807.85%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$9.68 B 1,154,989.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$4.19 M 400.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
A$1.13 B 135,398.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A$0.30 B 36,006.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$0.49 M-40.42%๐Ÿ‡บ๐Ÿ‡ธ USA